Page last updated: 2024-08-23

etoposide and Cancer of Mouth

etoposide has been researched along with Cancer of Mouth in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's0 (0.00)29.6817
2010's5 (55.56)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Chairatvit, K; Klaophimai, S; Pouyfung, P1
de Carvalho Fraga, CA; de Souza, MG; Farias, LC; GuimarĂ£es, ALS; GuimarĂ£es, TA; Jones, KM; Xavier, GM1
Byun, MR; Choi, JW; Kim, YR; Lee, B; Lee, JK1
Amadori, S; Anemona, L; Bruno, E; Buccisano, F; Cantonetti, M; Del Principe, MI; Franceschini, L; Mauramati, S; Meconi, F; Nasso, D; Onnis, I; Postorino, M; Provenzano, I; Pupo, L; Rizzo, M; Vaccarini, S; Zizzari, A1
Fericean, AM; Kolokotronis, AE; Matiakis, AT; Papamanthos, MK; Skulakis, HE; Zorba, MT1
Cho, JH; Cho, YJ; Kim, GC; Kim, S; Lee, MH; Park, BS1
Jayaram, L; Lee, L; Oppenheimer, R1
Ichikawa, G; Kohno, N; Kusunoki, M; Nakazawa, E; Nishiya, M1
Hyo, Y; Kitamura, K; Mori, M; Oshitani, T; Sawatari, S; Shiraishi, T; Takigami, K; Yamaguchi, Y; Yamamoto, G; Yoshitake, K1

Reviews

1 review(s) available for etoposide and Cancer of Mouth

ArticleYear
Pathways Related to the Anti-Cancer Effects of Metabolites Derived from Cerrado Biome Native Plants: An Update and Bioinformatics Analysis on Oral Squamous Cell Carcinoma.
    Protein and peptide letters, 2021, Volume: 28, Issue:7

    Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Brazil; Carcinogenesis; Carcinoma, Squamous Cell; Cell Proliferation; Computational Biology; Etoposide; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; Mouth Neoplasms; Neoplasm Proteins; Paclitaxel; Plant Extracts; Plants, Medicinal; Vinblastine

2021

Other Studies

8 other study(ies) available for etoposide and Cancer of Mouth

ArticleYear
Enhancing the Effective Chemotherapy: The Combined Inhibition of Rhinacanthin-C, 5-Fluorouracil, and Etoposide on Oral Cancer Cells.
    Asian Pacific journal of cancer prevention : APJCP, 2023, Jul-01, Volume: 24, Issue:7

    Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Etoposide; Fluorouracil; Humans; Mouth Neoplasms

2023
Evaluation of pemetrexed and etoposide as therapeutic regimens for human papillomavirus-positive oral and oropharyngeal cancer.
    PloS one, 2018, Volume: 13, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Screening Assays, Antitumor; Etoposide; Humans; Mouth Neoplasms; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus Infections; Pemetrexed; Pharyngeal Neoplasms

2018
A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy.
    Annals of hematology, 2016, Volume: 95, Issue:1

    Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Male; Middle Aged; Mouth Neoplasms; Mycosis Fungoides; Prednisolone; Skin Neoplasms; Treatment Outcome; Vincristine

2016
Acute myeloid leukaemia diagnosed by intra-oral myeloid sarcoma. A case report.
    Head and neck pathology, 2010, Volume: 4, Issue:2

    Topics: Aged; Antineoplastic Agents; Biopsy; Diagnosis, Differential; Etoposide; Fatal Outcome; Female; Humans; Leukemia, Myeloid, Acute; Mouth Mucosa; Mouth Neoplasms; Neoplasms, Multiple Primary; Sarcoma, Myeloid

2010
The bacterial protein azurin enhances sensitivity of oral squamous carcinoma cells to anticancer drugs.
    Yonsei medical journal, 2011, Volume: 52, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Azurin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclin B1; Drug Synergism; Etoposide; Fluorouracil; Humans; Mouth Neoplasms; Tumor Suppressor Protein p53

2011
Germ cell tumor metastatic to the oral cavity.
    Ear, nose, & throat journal, 2012, Volume: 91, Issue:4

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Bleomycin; Cisplatin; Etoposide; Humans; Male; Mouth; Mouth Neoplasms; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms

2012
Induction chemotherapy with cisplatin, etoposide, and mitomycin-C (PEM) regimen in advanced cases with cancer of pharynx and oral cavity.
    Auris, nasus, larynx, 1995, Volume: 22, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycin; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Remission Induction

1995
[A case of verrucous carcinoma showing a good partial response by C.P.E. (CDDP, PEP, etoposide) chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Papillary; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Mouth Neoplasms; Peplomycin; Remission Induction

1992